Semaglutide (GLP-1 RA)
Achieve weight loss goals safely and effectively with semaglutide, a proven and exciting solution.
Semaglutide is a medication used primarily to treat type 2 diabetes, though it has also been used in obesity management in non-diabetic individuals. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. This is the active ingredient in the commonly used medications Ozempic and Wegovy.
GLP-1 receptor agonist:
Semaglutide mimics the action of GLP-1, a hormone produced naturally in the body in response to food intake. GLP-1 helps regulate blood sugar levels by stimulating insulin secretion from the pancreas and reducing the production of glucagon (another hormone that raises blood sugar levels) by the liver.
Slows stomach emptying:
Semaglutide slows down the rate at which the stomach empties, which can help control appetite and reduce food intake. This effect contributes to weight loss in people with obesity.
Increases satiety:
By acting on the brain's appetite centers, semaglutide can help increase feelings of fullness or satiety after eating, leading to reduced calorie intake and weight loss.
Overall, semaglutide helps to improve blood sugar control in people with type 2 diabetes and aids in weight loss in individuals with obesity by multiple mechanisms, including increasing insulin secretion, reducing glucagon production, slowing stomach emptying, and promoting satiety.
BENEFITS:
Improved Blood
Sugar Control:
Semaglutide helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon production, which leads to better control of blood sugar levels in people with type 2 diabetes.
Weight
Loss:
Semaglutide has been found to promote weight loss in individuals with obesity. Its effects on slowing stomach emptying and increasing feelings of fullness contribute to reduced calorie intake and subsequent weight loss.
Cardiovascular
Benefits:
Some studies suggest that semaglutide may have cardiovascular benefits, such as reducing the risk of heart attack, stroke, and cardiovascular death, although more research is needed in this area.
Important Safety Information
For Important Safety Information Regarding Compounded Semaglutide Products